Master of Science in Health Informatics

Weiss & Company LLP Names Two New Partners

Retrieved on: 
Thursday, January 12, 2023

GLENVIEW, Ill., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Weiss & Company LLP has announced that senior managers Katherine Chung and Jeremy Morgan have been promoted to partners.

Key Points: 
  • GLENVIEW, Ill., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Weiss & Company LLP has announced that senior managers Katherine Chung and Jeremy Morgan have been promoted to partners.
  • Chung joined Weiss in 2019 as a senior tax manager with more than 20 years of experience in the profession.
  • She works closely with clients in diverse industries, including manufacturing, retail, distribution, real estate, professional practices, service companies, and restaurants.
  • "It is such a pleasure to become one of the new partners at Weiss," he said.

Jeff Weil Leads VITAS® Healthcare Hospice Operations in California

Retrieved on: 
Wednesday, November 30, 2022

SACRAMENTO, Calif., Nov. 30, 2022 /PRNewswire/ -- Jeff Weil is the new senior vice president of hospice operations for VITAS Healthcare in California.

Key Points: 
  • SACRAMENTO, Calif., Nov. 30, 2022 /PRNewswire/ -- Jeff Weil is the new senior vice president of hospice operations for VITAS Healthcare in California.
  • He brings more than 20 years of hospice and healthcare experience to the national leader's executive management team.
  • "I am proud to join the VITAS team and become part of an organization that helped pave the way for the hospice benefit .
  • Established in 1978, VITAS Healthcare is a pioneer and leader in the American hospice movement.

Fifth Eye Announces Andrew Malcolmson as new President & CEO

Retrieved on: 
Tuesday, November 1, 2022

ANN ARBOR, Mich., Nov. 1, 2022 /PRNewswire/ -- Fifth Eye , a leading provider of real-time AI-based clinical analytics today announced that its Board of Directors has appointed Andrew Malcolmson as its new President and Chief Executive Officer.

Key Points: 
  • ANN ARBOR, Mich., Nov. 1, 2022 /PRNewswire/ -- Fifth Eye , a leading provider of real-time AI-based clinical analytics today announced that its Board of Directors has appointed Andrew Malcolmson as its new President and Chief Executive Officer.
  • Andrew replaces Jen Baird who founded and led Fifth Eye from conception through product development, FDA clearance, and initial commercial release of their Analytic for Hemodynamic Instability (AHI) System.
  • Prior to joining Fifth Eye, Malcolmson was the General Manager of the Intra Oral Scanning (IOS) business unit at Carestream Dental where he recently led the $600M carve-out and sale of the business to Envista Holdings Corp.
    "Andrew has extensive experience in building partnerships that deliver strategic sales growth," Robert Kline, Executive Chairman, Fifth Eye, said.
  • Andrew will lead Fifth Eye to become the industry source that brings intelligence to data to inform better clinical decisions."

Joel S. Stoeckeler, MD is recognized by Continental Who's Who

Retrieved on: 
Thursday, October 27, 2022

During his years in full-time medical practice, Dr. Stoeckeler was a Family Medicine physician for over 26 years.

Key Points: 
  • During his years in full-time medical practice, Dr. Stoeckeler was a Family Medicine physician for over 26 years.
  • He additionally served as the EMS medical director for the Baldwin Ambulance Service for 18 years.
  • He continued his studies at the University of Minnesota, where he attended medical school, obtaining his Medical Degree in 1985.
  • Following medical school, Dr. Stoeckeler completed an internship in Pediatrics and a residency in Family Medicine at the University of Minnesota.

Bright Direction Dental Announces Nisheeth Singh as Chief Executive Officer

Retrieved on: 
Tuesday, October 4, 2022

CHICAGO, Oct. 4, 2022 /PRNewswire/ -- Bright Direction Dental (BDD) is pleased to appoint Nisheeth Singh its Chief Executive Officer.

Key Points: 
  • CHICAGO, Oct. 4, 2022 /PRNewswire/ -- Bright Direction Dental (BDD) is pleased to appoint Nisheeth Singh its Chief Executive Officer.
  • Mr. Singh joined BDD as Chief Operating Officer in late 2020.
  • Bright Direction Dental (BDD) is a Chicago-based premier dental support organization (DSO) that proudly partners with exceptional dental practices in Illinois, Indiana, Michigan, Ohio, and Missouri.
  • BDD was created to transform the dental experience for patients, clinicians, and its support teams, with over 20 partner dental practices.

Dialyze Direct Names Kim Hernandez Kuch as Chief Marketing Officer

Retrieved on: 
Thursday, September 8, 2022

Dialyze Direct , the nations leading provider of home hemodialysis services in skilled nursing facilities (SNFs), is pleased to announce the appointment of Kim Hernandez Kuch to the chief marketing officer (CMO) position, reporting to Chairman and Chief Executive Officer (CEO) Henry Kauftheil.

Key Points: 
  • Dialyze Direct , the nations leading provider of home hemodialysis services in skilled nursing facilities (SNFs), is pleased to announce the appointment of Kim Hernandez Kuch to the chief marketing officer (CMO) position, reporting to Chairman and Chief Executive Officer (CEO) Henry Kauftheil.
  • In her role, Hernandez Kuch will oversee the organization's marketing strategy, including demand generation, public relations, marketing communications, digital marketing, and events.
  • Our rapid growth in the past year made filling the chief marketing position a priority, and we are delighted Kim agreed to join our team.
  • Before joining Dialyze Direct, Hernandez Kuch co-founded healthcare think tank SWOT Health.

NIAAA: Dr. Paule Joseph Selected as the Inaugural American Academy of Nursing Fellow at the National Academy of Medicine

Retrieved on: 
Wednesday, August 17, 2022

M.S., FNP-BC, FAAN, is the inaugural 2022-2024 American Academy of Nursing (AAN) Fellow at the National Academy of Medicine (NAM).

Key Points: 
  • M.S., FNP-BC, FAAN, is the inaugural 2022-2024 American Academy of Nursing (AAN) Fellow at the National Academy of Medicine (NAM).
  • Dr. Joseph 's selection will be announced in person at the Annual Meeting of the NAM in Washington, D.C. on Monday, October 17.
  • "I congratulate Dr. Joseph on her selection for this first-of-its-kind fellowship," said George F. Koob, Ph.D., Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
  • Dr. Joseph is a researcher at the NIAAA with a joint appointment at the National Institute of Nursing Research (NINR).

Joel S. Stoeckeler, MD, is being recognized by Continental Who's Who

Retrieved on: 
Monday, August 15, 2022

During his years in full-time medical practice, Dr. Stoeckeler was a Family Medicine physician for over 26 years.

Key Points: 
  • During his years in full-time medical practice, Dr. Stoeckeler was a Family Medicine physician for over 26 years.
  • He additionally served as the EMS medical director for the Baldwin Ambulance Service for 18 years.
  • He continued his studies at the University of Minnesota, where he attended medical school, obtaining his Medical Degree in 1985.
  • Following medical school, Dr. Stoeckeler completed an internship in Pediatrics and a residency in Family Medicine at the University of Minnesota.

GeneIQ Announces Appointment of New Chief Commercial Officer

Retrieved on: 
Monday, July 18, 2022

DALLAS, July 18, 2022 /PRNewswire/ -- GeneIQ, a molecular diagnostics (MDx) company based in Dallas, Texas, welcomes Sami Shihabi as their new Chief Commercial Officer. With more than twenty-five years of experience in healthcare, Sami will lead the commercial branch of the organization that will encompass sales, marketing, and revenue cycle management functions with the goal of aligning them to achieve the company's corporate and financial goals. 

Key Points: 
  • DALLAS, July 18, 2022 /PRNewswire/ -- GeneIQ , a molecular diagnostics (MDx) company based in Dallas, Texas, welcomes Sami Shihabi as their new Chief Commercial Officer.
  • His experience in successfully building and leading commercial organizations will help GeneIQ expand its commercial presence in the marketplace.
  • Sami is an established commercial leader with extensive knowledge in the healthcare industry and commercial leadership in the therapeutics and diagnostics industries.
  • Prior to Progenity, Sami served as Chief Commercial Officer at Prometheus Laboratories.

DGAP-News: Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén

Retrieved on: 
Wednesday, July 6, 2022

The company also announced that Jan Van den Bossche has stepped down from the Board, effective July 5, 2022.

Key Points: 
  • The company also announced that Jan Van den Bossche has stepped down from the Board, effective July 5, 2022.
  • I look forward to working with Maria and to leveraging her extensive knowledge and relationships.
  • I would also like to take this opportunity to thank Jan for his dedication to Immunic and his invaluable input as a member of the Board of Directors over the last several years.
  • We are very grateful for his contributions and offer him our best wishes in all future endeavors.